FDA
-
-
-
-
-
-
-
Catholic Health and GE HealthCare sign $500M, 10-year technology deal
-
-
-
-
-
-
-
GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
-
-
-
-
-
-
-
GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imagin
-
-
-
-
-
-
-
GE HealthCare to showcase comprehensive cardiology portfolio at ACC.26, including its latest AI-enabled imaging technologies, advanced software solutions, and key collaborations
-
-
-
-
-
-
-
GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency
-
-
-
-
-
-
-
GE HealthCare unveils NVIDIA-powered imaging systems at RSNA 2025
-
-
-
-
-
-
-
GE HealthCare unveils Pristina Recon DL for mammography – deep learning image reconstruction technology delivering clearer image quality
-
334,273 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


